Follow-up Review of the Medicaid Drug Rebate Program in Florida

We conducted a follow-up audit of Florida's Medicaid drug rebate program to determine whether the State agency had (1) implemented the recommendations made in our previous audit of the Florida drug rebate program and (2) established controls over the drug rebate program, including the collection of rebates on single-source drugs administered by physicians.  Manufacturers may make their outpatient drugs eligible for Federal Medicaid funding by entering into a rebate agreement with CMS and paying quarterly rebates to the States.  We found that the State had implemented the recommendations from our prior audit.  Therefore, this report contains no recommendations.